96 related articles for article (PubMed ID: 30778016)
21. Nemo-like kinase (NLK) expression in osteoblastic cells and suppression of osteoblastic differentiation.
Nifuji A; Ideno H; Ohyama Y; Takanabe R; Araki R; Abe M; Noda M; Shibuya H
Exp Cell Res; 2010 Apr; 316(7):1127-36. PubMed ID: 20116374
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-208a Potentiates Angiotensin II-triggered Cardiac Myoblasts Apoptosis via Inhibiting Nemo-like Kinase (NLK).
Huang Y; Yang Y; He Y; Huang C; Meng X; Li J
Curr Pharm Des; 2016; 22(31):4868-4875. PubMed ID: 26861724
[TBL] [Abstract][Full Text] [Related]
23. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
24. Nemo-like kinase (NLK) primes colorectal cancer progression by releasing the E2F1 complex from HDAC1.
Li SZ; Zeng F; Li J; Shu QP; Zhang HH; Xu J; Ren JW; Zhang XD; Song XM; Du RL
Cancer Lett; 2018 Sep; 431():43-53. PubMed ID: 29803790
[TBL] [Abstract][Full Text] [Related]
25. Expression of Nemo-like kinase (NLK) in the brain in a rat experimental subarachnoid hemorrhage model.
Chen G; Feng D; Zhang L; Dang B; Liu H; Wang Z
Cell Biochem Biophys; 2013 Jul; 66(3):671-80. PubMed ID: 23325309
[TBL] [Abstract][Full Text] [Related]
26. Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus.
Brott BK; Pinsky BA; Erikson RL
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):963-8. PubMed ID: 9448268
[TBL] [Abstract][Full Text] [Related]
27. Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells.
Yasuda J; Tsuchiya A; Yamada T; Sakamoto M; Sekiya T; Hirohashi S
Biochem Biophys Res Commun; 2003 Aug; 308(2):227-33. PubMed ID: 12901858
[TBL] [Abstract][Full Text] [Related]
28. Angiogenesis and vascular growth factor receptor expression in malignant melanoma.
Lin EY; Piepkorn M; Garcia R; Byrd D; Tsou R; Isik FF
Plast Reconstr Surg; 1999 Nov; 104(6):1666-74. PubMed ID: 10541167
[TBL] [Abstract][Full Text] [Related]
29. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer.
Han Y; Kuang Y; Xue X; Guo X; Li P; Wang X; Guo X; Yuan B; Zhi Q; Zhao H
Biomed Pharmacother; 2014 Jun; 68(5):497-505. PubMed ID: 24972723
[TBL] [Abstract][Full Text] [Related]
30. The correlation of angiogenesis with metastasis in primary cutaneous melanoma: a comparative analysis of microvessel density, expression of vascular endothelial growth factor and basic fibroblastic growth factor.
Demirkesen C; Büyükpinarbaşili N; Ramazanoğlu R; Oğuz O; Mandel NM; Kaner G
Pathology; 2006 Apr; 38(2):132-7. PubMed ID: 16581653
[TBL] [Abstract][Full Text] [Related]
31. The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer.
Zhao Z; Liu W; Liu J; Wang J; Luo B
J Med Virol; 2017 Oct; 89(10):1844-1851. PubMed ID: 28543390
[TBL] [Abstract][Full Text] [Related]
32. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P
PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791
[TBL] [Abstract][Full Text] [Related]
33. Nemo-like kinase (NLK) acts downstream of Notch/Delta signalling to downregulate TCF during mesoderm induction in the sea urchin embryo.
Röttinger E; Croce J; Lhomond G; Besnardeau L; Gache C; Lepage T
Development; 2006 Nov; 133(21):4341-53. PubMed ID: 17038519
[TBL] [Abstract][Full Text] [Related]
34. Differentially expressed genes identified in human melanoma cell lines with different metastatic behaviour using high density oligonucleotide arrays.
de Wit NJ; Burtscher HJ; Weidle UH; Ruiter DJ; van Muijen GN
Melanoma Res; 2002 Feb; 12(1):57-69. PubMed ID: 11828259
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of nemo-like kinase increases taxol sensitivity in laryngeal cancer.
Dong JR; Guo N; Zhao JP; Liu PD; Feng HH; Li Y
Asian Pac J Cancer Prev; 2013; 14(12):7137-41. PubMed ID: 24460265
[TBL] [Abstract][Full Text] [Related]
36. Expression of NLK and its potential effect in ovarian cancer chemotherapy.
Zhang Y; Peng C; Wu G; Wang Y; Liu R; Yang S; He S; He F; Yuan Q; Huang Y; Shen A; Cheng C
Int J Gynecol Cancer; 2011 Nov; 21(8):1380-7. PubMed ID: 22027747
[TBL] [Abstract][Full Text] [Related]
37. Comparative genomics on nemo-like kinase gene.
Katoh M; Katoh M
Int J Oncol; 2005 Jun; 26(6):1715-9. PubMed ID: 15870890
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis correlates with metastasis in melanoma.
Neitzel LT; Neitzel CD; Magee KL; Malafa MP
Ann Surg Oncol; 1999; 6(1):70-4. PubMed ID: 10030417
[TBL] [Abstract][Full Text] [Related]
39. Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma.
Jung KH; Kim JK; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Park WS; Lee JY; Nam SW
J Cell Biochem; 2010 Jun; 110(3):687-96. PubMed ID: 20512928
[TBL] [Abstract][Full Text] [Related]
40. JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma.
Lu J; Tang Y; Farshidpour M; Cheng Y; Zhang G; Jafarnejad SM; Yip A; Martinka M; Dong Z; Zhou J; Xu J; Li G
Carcinogenesis; 2013 Dec; 34(12):2778-88. PubMed ID: 24064223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
